Serum Institute of India chief Adar Poonawalla on Thursday said that he was deeply saddened by the loss of lives in the fire at the vaccine-maker's facility in Pune which is at the heart of India's fight against the coronavirus. Five people have died in the fire. | NDTV

The Serum Institute of India produces 5,000 doses every minute of India's first coronavirus vaccine Covishield. NDTV brings to you this exclusive report from SII, where we interact with CEO Adar Poonawalla who talks about the massive production and answers questions about the vaccine. | NDTV

Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca, sources have said. The Pune-based pharma firm is the second to do so, say sources, after American firm Pfizer sought approval from the drug regulator - the DCGI (Drugs Controller General of India)- for its COVID-19 vaccine, cleared by

11K views · 38 reactions | Watch Serum Institute of India's CEO, Adar Poonawalla 's exclusive interview on Covishield vaccine's approval in India. | News18 | Facebook

Adar Poonawalla, the CEO of the Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting Covid vaccine trials ahead of mass production - took to Twitter today to highlight potential challenges ahead of vaccine production and distribution in the country. | NDTV